Pore formation by beta-2-microglobulin: a mechanism for the pathogenesis of dialysis associated amyloidosis

被引:59
|
作者
Hirakura, Y
Kagan, BL
机构
[1] Univ Calif Los Angeles, Inst Neuropsychiat, Dept Psychiat, Sch Med,Brain Res Inst, Los Angeles, CA 90024 USA
[2] Univ Calif Los Angeles, Sch Med, Mental Retardat Res Ctr, Los Angeles, CA 90024 USA
[3] W Los Angeles Vet Affairs Med Ctr, Los Angeles, CA 90073 USA
来源
关键词
beta-2-microglobulin; dialysis amyloidosis; pore formation;
D O I
10.3109/13506120109007350
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Beta-2 microglobulin (beta 2M, molecular weight 10,000) is a 99 residue immune system protein which is part of the MHC Class I complex whose role is to present antigens to T cells. beta 2M serum levels rise dramatically in renal failure, and a syndrome called " dialysis associated amyloidosis " occurs with time in a majority of hemodialysis patients who exhibit beta 2M amyloid deposits in joints, bone and other organs(1). beta 2M can also induce Ca++ efflux from calvariae, collagenase production, and bone resportion(2-1). We report here that beta 2M formed relatively nonselective, long-lived, voltage independent ion channels in planar phospholipid bilayer membranes at physiologically relevant concentrations. The channels were inhibited by Congo red and blocked by zinc suggesting that they exist in an aggregated beta sheet stale as is common with other amyloid fibril forming peptides. Multiple single channel conductances were seen suggesting that various oligomers of beta 2M may be capable of forming channel structures. We suggest that beta 2M channel formation may account for some of the pathophysiologic effects seen in dialysis associated amyloidosis. These findings lend further weight to the "channel hypothesis" of amyloid pathogenesis.
引用
收藏
页码:94 / 100
页数:7
相关论文
共 50 条
  • [1] BETA-2-MICROGLOBULIN, AMYLOIDOSIS, AND DIALYSIS
    ACCHIARDO, S
    [J]. INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 1988, 11 (04): : 229 - 231
  • [2] BETA-2-MICROGLOBULIN SERUM CONCENTRATION AND ASSOCIATED AMYLOIDOSIS IN DIALYSIS PATIENTS
    STEIN, G
    SCHNEIDER, A
    THOSS, K
    RITZ, E
    SCHAEFER, K
    HULLER, M
    SPERSCHNEIDER, H
    MARZOLL, I
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 1991, 6 : 57 - 61
  • [3] HEMODIALYSIS MEMBRANES, SERUM BETA-2-MICROGLOBULIN, AND DIALYSIS AMYLOIDOSIS
    HAUGLUSTAINE, D
    WAER, M
    MICHIELSEN, P
    GOEBELS, J
    VANDEPUTTE, M
    [J]. LANCET, 1986, 1 (8491): : 1211 - 1212
  • [4] BETA-2-MICROGLOBULIN AMYLOIDOSIS
    SAITO, A
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 1994, 9 : 116 - 119
  • [5] DIAGNOSIS OF BETA-2-MICROGLOBULIN ASSOCIATED AMYLOIDOSIS BY SCINTIGRAPHY
    FLOEGE, J
    SCHAEFFER, J
    KOCH, KM
    [J]. REVUE DU RHUMATISME, 1994, 61 (09): : S39 - S42
  • [6] BETA-2-MICROGLOBULIN AMYLOIDOSIS AS A COMPLICATION OF PERITONEAL-DIALYSIS TREATMENT
    BENHAMOU, CL
    BARDIN, T
    NOEL, LH
    CORNELIS, F
    TOURLIERE, D
    MAITRE, F
    PIERRE, D
    [J]. CLINICAL NEPHROLOGY, 1988, 30 (06) : 346 - 346
  • [7] DIALYSIS AMYLOIDOSIS - BETA-2-MICROGLOBULIN IN THE CONTEXT OF OTHER AMYLOIDOGENIC PROTEINS
    GOREVIC, PD
    MUNOZ, P
    [J]. BLOOD PURIFICATION, 1988, 6 (02) : 132 - 144
  • [8] BETA-2-MICROGLOBULIN AMYLOIDOSIS IN LONG-TERM DIALYSIS PATIENTS
    STONE, WJ
    HAKIM, RM
    [J]. AMERICAN JOURNAL OF NEPHROLOGY, 1989, 9 (03) : 177 - 183
  • [9] BETA-2-MICROGLOBULIN AND DIALYSIS-RELATED AMYLOIDOSIS - RECENT DEVELOPMENTS
    FLOEGE, J
    WILKS, MF
    GRANOLLERAS, C
    SHALDON, S
    KOCH, KM
    [J]. IMPROVEMENTS IN DIALYSIS THERAPY, 1989, 74 : 120 - 126
  • [10] DIALYSIS AMYLOIDOSIS WITH MASSIVE POPLITEAL DEPOSITION OF BETA-2-MICROGLOBULIN AMYLOID
    BRANCACCIO, D
    GALLIENI, M
    PADOVESE, P
    ANELLI, A
    COGGI, G
    USLENGHI, C
    [J]. LANCET, 1988, 2 (8614): : 802 - 802